Histoplasmosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 20: | Line 20: | ||
{{SK}} Ajellomyces capsulatus; Darling disease; Darling's disease | {{SK}} Ajellomyces capsulatus; Darling disease; Darling's disease | ||
==Overview== | ==[[Histoplasmosis overview|Overview]]== | ||
== | ==[[Histoplasmosis historical perspective|Historical Perspective]]== | ||
== | ==[[Histoplasmosis pathophysiology|Pathophysiology]]== | ||
== | ==[[Histoplasmosis causes|Causes]]== | ||
==[[Histoplasmosis differential diagnosis|Differentiating Histoplasmosis from other Diseases]]== | |||
==[[Histoplasmosis epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Histoplasmosis risk factors|Risk Factors]]== | |||
==[[Histoplasmosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
== | ==Diagnosis== | ||
[[Histoplasmosis history and symptoms|History and Symptoms]] | [[Histoplasmosis physical examination|Physical Examination]] | [[Histoplasmosis laboratory findings|Laboratory Findings]] | [[Histoplasmosis x rays|X Rays]] | [[Histoplasmosis other imaging findings|Other Imaging Findings]] | [[Histoplasmosis other diagnostic studies|Other Diagnostic Studies]] | |||
== | ==Treatment== | ||
[[Histoplasmosis medical therapy|Medical Therapy]] | [[Histoplasmosis primary prevention|Primary Prevention]] | [[Histoplasmosis secondary prevention|Secondary Prevention]] | [[Histoplasmosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Histoplasmosis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Histoplasmosis case study one|Case #1]] | |||
==External links== | ==External links== | ||
*[http://www.nei.nih.gov/health/histoplasmosis/index.asp Histoplasmosis] Resource Guide from the National Eye Institute (NEI). | *[http://www.nei.nih.gov/health/histoplasmosis/index.asp Histoplasmosis] Resource Guide from the National Eye Institute (NEI). | ||
*[http://www.cdc.gov/niosh/docs/2005-109/ NIOSH - Histoplasmosis - Protecting Workers at Risk] | *[http://www.cdc.gov/niosh/docs/2005-109/ NIOSH - Histoplasmosis - Protecting Workers at Risk] | ||
{{Mycoses}} | {{Mycoses}} | ||
Revision as of 15:44, 26 September 2012
| Histoplasmosis | |
 | |
|---|---|
| Histoplasma capsulatum. Methenamine silver stain showing histopathologic changes in histoplasmosis. | |
| ICD-10 | B39 |
| ICD-9 | 115 |
| DiseasesDB | 5925 |
| MedlinePlus | 001082 |
| MeSH | D006660 |
|
Histoplasmosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Histoplasmosis On the Web |
|
American Roentgen Ray Society Images of Histoplasmosis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Ajellomyces capsulatus; Darling disease; Darling's disease
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Histoplasmosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Rays | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
- Histoplasmosis Resource Guide from the National Eye Institute (NEI).
- NIOSH - Histoplasmosis - Protecting Workers at Risk